Arabella Young

10PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityRadiation therapyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 23, 2026
Associations Between Two-Year Immune-Related Adverse Events and Psychological Distress and Subsequent Survival Outcomes Among ICI-Treated Survivors Diagnosed With Advanced Cancers in the US.

|Dec 03, 2025
The impact of concomitant medications on treatment outcomes in patients with cancer receiving immune checkpoint inhibitors.

Samantha Stone, Jordan P McPherson, Rajan P Kulkarni

|Aug 14, 2025
Autoimmune origin for immune checkpoint inhibitor-diabetes revealed by deep immune phenotyping of the pancreas.

Zoe Quandt, Arabella Young, Graham Larson Barlow

|May 12, 2025
Associations between immune checkpoint inhibitor response, immune-related adverse events, and steroid use in RADIOHEAD: a prospective pan-tumor cohort study.

Zoe Quandt, Anastasia Lucas, Samantha I Liang

|Nov 08, 2024
Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response.

Zoe Quandt, Saya Jacob, Muhammad Zaki Hidayatullah Fadlullah

|Aug 11, 2023
Stocking the toolbox-Using preclinical models to understand the development and treatment of immune checkpoint inhibitor-induced immune-related adverse events.

Morgan L Cina, Jessica Venegas, Arabella Young

Pageof 2

Frequent Collaborators

3 joint publications

Zoe Quandt

2 joint publications

Adil I Daud

2 joint publications

Muhammad Zaki Hidayatullah Fadlullah

2 joint publications

Samantha Stone